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Secondary hyperparathyroidism in HIV-infected patients:
relationship with bone remodeling and response to vitamin D
supplementation
Ban ˜on, S; Del Palacio, M; Pe ´rez Elı ´as, M; Moreno, A; Moreno, S; Dronda, F and Casado, J
Ramon y Cajal Hospital, Infectious Diseases, Madrid, Spain.
Purpose of the study
Secondary hyperparathyroidism (SH) is frequent in HIV-infected patients. However, the causes and consequences are not well
established. The aim of our study was to determine the relationship between parathyroid hormone (PTH), vitamin D and bone
mineral density (BMD) in HIV-infected patients, and the effect of vitamin D replacement on PTH levels.
Methods
Prospective study of 506 patients with at least two sequential serum determinations of PTH and 25-hydroxyvitamin D levels. In
all cases, a bone dual X-ray absorptiometry (DEXA) was performed at inclusion. Hyperparathyroidism was defined as a PTH level
above 65 pg/ml.
Summary of results
Mean age was 44 yrs (2478), and 75% were male. Mean BMI was 23.7 (17.9733.11), and only 3% were of black race. Median
nadir CD4 was 200 cells/mL( 9 499), and median time of HIV infection was 15.3 yrs (1.725.2). At inclusion, 488 patients
(86%) were on HAART (31% TDFPI, 44% TDFNNRTI, 25% non-TDF based regimen) for a median of 929.5 days (1541969),
and 40% were HCV-coinfected. Median eGFR was 97.9 ml/min (62.14134.08). Overall, mean serum PTH was 56.3 pg/mL (27.2
95.07). SH was observed in 27% of cases, with a marked influence of seasonality (from 44% in January to 10% in August). Mean
levels of vitamin D were 17.45 ng/mL (7.640.78), with 16% below 10 ng/ml, 59%B20 ng/ml (deficiency), 85%B30 ng/ml
(insufficiency). SH was related to vitamin D deficiency (relative risk, RR, 2.44), age (RR 1.04 per year), and a higher decrease in
eGFR (RR 1.03 per ml/min), after adjustment by season, antiretroviral therapy, GFR at baseline, and HCV coinfection. DEXA scan
showed 18% osteoporosis and 54% osteopenia, and there was an inverse correlation between PTH levels and T and Z score in
femoral neck (r0.14, pB0.01), higher in those patients below 40 yrs.Vitamin D supplementation in 181 patients produced
a significant decrease in serum PTH (57.2 if not treated vs 50.5 pg/ml, p0.02, 23% continues with SH) and the only factor
associated with lack of response was persistent vitamin D deficiency.
Conclusion
SH is relatively frequent in HIV patients, in close relation with vitamin D deficiency. It is associated with bone resorption,
especially in the femoral neck. The use of vitamin D supplementation improves SH when levels above 20 ng/ml are achieved.
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